Mitoxantrone, etoposide and intermediate-dose ara-c (MEC) for the treatment of acute myelogenous leukemia (AML)

S. Amadori, A. Spadea, M. C. Petti, P. Fazi, G. Meloni, A. P. Iori, A. Picardi, M. Rolla, F. Mandelli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)69
Number of pages1
JournalLeukemia and Lymphoma
Issue numberS2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this